Incretin-based Drugs Industry News: In September 2025, Pfizer announced it had entered a definitive agreement to acquire Metsera, a clinicalstage developer advancing nextgeneration obesity and cardiometabolic therapies
As well as GLP-1 receptors, the drug activates glucagon receptors
3,4 Furthermore, GLP-1R agonists have multiple biological effects that can treat obesity, cardiovascular, neurological, metabolic diseases and play a positive role in tumor therapy
Acknowledge and reward yourself for reaching milestones along the way
Common mild effects Less common effects All protocols at Nuceria are carefully monitored to ensure results and safety
Monitor renal function in patients reporting adverse reactions to Ozempic or Rybelsus tablets that could lead to volume depletion, especially during initiation and escalation of Ozempic or Rybelsus tablets Severe Gastrointestinal (GI) Adverse Reactions: Use of semaglutide tablets has been associated with GI adverse reactions, sometimes severe